Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lisa Baderoon Insider Profile
4 Followers
Lisa Baderoon, Investor Relations Head at ImmuPharma, holds 1.58M shares in ImmuPharma (Ticker: GB:IMM). Most recently, Lisa Baderoon Bought 1,000,000p shares of ImmuPharma on Sep 07, 2023 for an estimated value of 20.00K.
Lisa Baderoon ImmuPharma (IMM)Investor Relations Head
ImmuPharma (IMM)
Investor Relations Head
Ranked #73,915 out of 98,624 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-22.20%
Average return per transaction
Time Frame
Compare to
Insider Roles
Investor Relations Head
Roles that Lisa Baderoon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Lisa Baderoon
Lisa Baderoon's Trading History
List of latest transactions for each holding click on a transaction to see Lisa Baderoon's performance on stock
You May Also Like
Lisa Baderoon insider profile FAQ
What is the percentage of profitable transactions made by Lisa Baderoon?
The percentage of profitable transactions made by Lisa Baderoon is 33%.
What is the average return per transaction made by Lisa Baderoon?
The average return per transaction made by Lisa Baderoon is -22.20%.
What stocks does Lisa Baderoon hold?
Lisa Baderoon holds: GB:IMM stocks.
What was Lisa Baderoon’s latest transaction?
Lisa Baderoon latest transaction was an Informative Buy of 20.00K.
What was Lisa Baderoon's most profitable transaction?
Lisa Baderoon’s most profitable transaction was an Informative Buy of GB:IMM stock on September 7, 2023. The return on the trade was 4.60%.
What is Lisa Baderoon's role in ImmuPharma?
Lisa Baderoon's role in ImmuPharma is Investor Relations Head.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.